IRSN
John Carson , Irvine Sensors CEO, said, “Once the required delivery schedules of the government customer are fully known, we expect that the amount of our subcontract will ultimately exceed $18 million in support of this job.”
TSHO
The Tradeshow Marketing Company, Ltd. (Pink Sheets: TSHO) today announced that it will be hosting a shareholder conference call on February 10, 2010 at 10:00 A.M. Pacific Time / 1:00 P.M. Eastern Time . Luniel de Beer , President and CEO of Tradeshow Marketing , will discuss the current status of the company and outline the vision for the coming year.
SNSS
(NASDAQ: SNSS) today announced that it has granted Carmot Therapeutics, Inc. , a privately-held biotechnology company, an exclusive license to its proprietary Fragment-Based Lead Discovery (FBLD) technology. Carmot will use the FBLD technology, called “Chemotype Evolution,” for identifying promising drug candidates in a broad range of therapeutic areas, including inflammatory, metabolic, and neurodegenerative diseases.
